Hogan Lovells has standout practices based in China, Japan and Vietnam, covering the whole range of IP issues, including global and regional portfolio management, trade secrets, copyright and design protection. Known for a particularly strong offering on disputes within the life sciences industry. Acts for an impressive roster of clients across the pharmaceutical, food and drink, entertainment, retail, TMT and consumer goods sectors. Established competence in handling IP-related unfair competition cases.

One impressed client sums up: "They do an outstanding job in keeping me informed and involved, and are highly responsive to my questions and suggestions. They have a deep understanding of not only the legal issues impacting our industry, but also our business and commercial priorities. They are able to expertly incorporate our business considerations into a comprehensive legal strategy. They are especially valuable for handling complex legal matters involving complicated or novel issues as they can provide high-quality and sophisticated legal services."

"The lawyers are very efficient and very proactive, you feel you are the only client to them," adds another source.

Acted for Caterpillar on two trade mark invalidation and opposition cases involving the 'KAT' trade mark and its back-up application against an infringer before the Supreme People's Court. The Hogan Lovells team worked closely with Fujian Fidelity, and secured favourable rulings for Caterpillar.

Hogan Lovells represented Merck & Co in its patent litigation against Shionogi relating to Isentress, its HIV integrase inhibitor product.

Helen Xia is the head of the firm's Asia-Pacific IP practice. My Doan is a key contact for the Vietnam IP practice. Feng Zhen is a main contact for the China IP practice.